Literature DB >> 24902976

Antiplatelet and anticoagulation therapy for acute coronary syndromes.

Deepak L Bhatt1, Jean-Sébastien Hulot2, David J Moliterno2, Robert A Harrington2.   

Abstract

The past 2 decades have witnessed the introduction and demise of several different antithrombotic medications for acute coronary syndromes. Part of the assessment of these compounds has been their effect on thrombotic events relative to the degree of increase in bleeding events. This review will outline the data supporting various antiplatelet and anticoagulant therapies and their combinations in patients with acute coronary syndromes and related disorders in both the acute and chronic phases of therapy.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  acute coronary syndrome; hemorrhage; myocardial infarction

Mesh：

Substances：

Year:  2014        PMID： 24902976     DOI： 10.1161/CIRCRESAHA.114.302737

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


  19 in total

Review 1.  Optimization of Antiplatelet Therapy in STEMI.

Authors:  Abhishek Sinha; Kush Agrawal; Rahul Sakhuja
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-08

Review 2.  Antithrombotic Therapy After Percutaneous Coronary Intervention in Atrial Fibrillation: The Triple Trouble.

Authors:  Massimo Leggio; Augusto Fusco; Paolo Severi; Mario Lombardi; Elisa Caldarone; Stefania D'Emidio; Massimo Armeni; Daniela Mereu; Maria Grazia Bendini; Andrea Mazza
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

3.  Cardiovascular events after discontinuation of low-dose aspirin.

Authors:  Manan Pareek; Steen D Kristensen; Erik L Grove
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

4.  Double Antithrombotic versus Triple Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome.

Authors:  Surya Dharma
Journal:  Int J Angiol       Date:  2020-03-21

Review 5.  Management of Oral Anticoagulation and Antiplatelet Therapy in Post-Myocardial Infarction Patients with Acute Ischemic Stroke with and without Atrial Fibrillation.

Authors:  Francesca Romana Pezzella; Marilena Mangiardi; Mario Ferrante; Sebastiano Fabiano; Sabrina Anticoli; Fabrizio Giorgio Pennacchi; Antonella Urso; Leonardo De Luca; Valeria Caso
Journal:  J Clin Med       Date:  2022-07-04       Impact factor: 4.964

6.  No indications for platelet activation in acute clinical myocardial or renal ischemia/reperfusion injury.

Authors:  Kirsten A Kortekaas; Dorottya K de Vries; Mark Roest; Marlies Ej Reinders; Eric P van der Veer; Robert Jm Klautz; Philip G de Groot; Alexander F Schaapherder; Jan H Lindeman
Journal:  Am J Transl Res       Date:  2018-03-15       Impact factor: 4.060

7.  Brazilian Society of Cardiology Guidelines on Unstable Angina and Acute Myocardial Infarction without ST-Segment Elevation - 2021.

Authors:  José Carlos Nicolau; Gilson Soares Feitosa Filho; João Luiz Petriz; Remo Holanda de Mendonça Furtado; Dalton Bertolim Précoma; Walmor Lemke; Renato Delascio Lopes; Ari Timerman; José A Marin Neto; Luiz Bezerra Neto; Bruno Ferraz de Oliveira Gomes; Eduardo Cavalcanti Lapa Santos; Leopoldo Soares Piegas; Alexandre de Matos Soeiro; Alexandre Jorge de Andrade Negri; Andre Franci; Brivaldo Markman Filho; Bruno Mendonça Baccaro; Carlos Eduardo Lucena Montenegro; Carlos Eduardo Rochitte; Carlos José Dornas Gonçalves Barbosa; Cláudio Marcelo Bittencourt das Virgens; Edson Stefanini; Euler Roberto Fernandes Manenti; Felipe Gallego Lima; Francisco das Chagas Monteiro Júnior; Harry Correa Filho; Henrique Patrus Mundim Pena; Ibraim Masciarelli Francisco Pinto; João Luiz de Alencar Araripe Falcão; Joberto Pinheiro Sena; José Maria Peixoto; Juliana Ascenção de Souza; Leonardo Sara da Silva; Lilia Nigro Maia; Louis Nakayama Ohe; Luciano Moreira Baracioli; Luís Alberto de Oliveira Dallan; Luis Augusto Palma Dallan; Luiz Alberto Piva E Mattos; Luiz Carlos Bodanese; Luiz Eduardo Fonteles Ritt; Manoel Fernandes Canesin; Marcelo Bueno da Silva Rivas; Marcelo Franken; Marcos José Gomes Magalhães; Múcio Tavares de Oliveira Júnior; Nivaldo Menezes Filgueiras Filho; Oscar Pereira Dutra; Otávio Rizzi Coelho; Paulo Ernesto Leães; Paulo Roberto Ferreira Rossi; Paulo Rogério Soares; Pedro Alves Lemos Neto; Pedro Silvio Farsky; Rafael Rebêlo C Cavalcanti; Renato Jorge Alves; Renato Abdala Karam Kalil; Roberto Esporcatte; Roberto Luiz Marino; Roberto Rocha Corrêa Veiga Giraldez; Romeu Sérgio Meneghelo; Ronaldo de Souza Leão Lima; Rui Fernando Ramos; Sandra Nivea Dos Reis Saraiva Falcão; Talia Falcão Dalçóquio; Viviana de Mello Guzzo Lemke; William Azem Chalela; Wilson Mathias Júnior
Journal:  Arq Bras Cardiol       Date:  2021-07       Impact factor: 2.667

8.  Effect of Dialysis on Antiplatelet Drug Efficacy in Uremic Patients with Coronary Heart Disease.

Authors:  Dong-Liang Fu; Ting-Ting Zhao; Wen-Hua Peng; Peng Yang; Xiao-Fei Liu; Hu Zhang; Xian-Lun Li; Yong Wang; Jin-Gang Zheng; Yan-Xiang Gao; Hong-Kai Lu; Qi Wang
Journal:  Chin Med J (Engl)       Date:  2017-08-20       Impact factor: 2.628

Review 9.  The management of antiplatelet therapy in acute coronary syndrome patients with thrombocytopenia: a clinical conundrum.

Authors:  Cian P McCarthy; Gabriel Steg; Deepak L Bhatt
Journal:  Eur Heart J       Date:  2017-12-14       Impact factor: 29.983

10.  Safety and Incidence of Cardiovascular Events in Chinese Patients with Acute Coronary Syndrome Treated with Ticagrelor: the 12-Month, Phase IV, Multicenter, Single-Arm DAYU Study.

Authors:  Runlin Gao; Yongjian Wu; Hengliang Liu; Guohai Su; Zuyi Yuan; Aidong Zhang; Yong Wang; Zhirong Wang; Yan Wang; Huanyi Zhang; Yang Zheng; Lei Liu; Lijun Shen; Maria Leonsson-Zachrisson; Yaling Han
Journal:  Cardiovasc Drugs Ther       Date:  2018-02       Impact factor: 3.727
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.